The U.S. Centers for Medicare and Medicaid Services has named Novo Nordisk’s Wegovy, Ozempic and Rybelsus as part of the ...

WASHINGTON (AP) — Popular weight loss and diabetes drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

Its weight-loss drug policy would fall to Trump's pick for health secretary, Robert F Kennedy Jr, and Mehmet Oz, Trump's choice to lead Medicare and Medicaid services. But this could mean a potential ...

Included are Type-2 diabetes drugs Janumet, Janumet XR, Ozempic, Rybelsus, Tradjenta and Wegovy. The federal Centers for Medicare and Medicaid Services disclosed the 15 drugs that would be covered ...

New year, new president, new round of Medicare drug pricing negotiations to parse through ... Brand names topping the list included Novo Nordisk’s Ozempic and Wegovy, Astellas Pharma’s Xtandi, and ...

Kennedy is nominated to lead the Department of Health and Human Services, a position that would give him enormous control ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Novo Nordisk’s NVO shares gained 8.5% on Friday after the company announced positive top-line data from an early to mid-stage ...

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Concern is growing among Democrats after President Donald Trump reversed some of the former president's executive orders, ...